Skip to main content
TSHA logo

TSHA · Taysha Gene Therapies, Inc. · Held by Funds

Track TSHA — free
$3.99 -0.01 (-0.25%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.30B
Shares
326.05M
Volume · Nov 18 3.55M Avg daily vol (3M) 3.62M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of TSHA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 12.76% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.43% 7,912,990
Index ETFs 10.34% 33,704,871
Active ETFs 0.44% 1,438,708
Active funds 4.17% 13,608,618
Unclassified 0.00% 4,999
All registered funds 17.38% 56,670,186
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding TSHA

169 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 169 positions
Key facts CIK 1806310 CUSIP 877619106 13F (30d) 217 filings 199 filers Visit website Investor relations